Statements (64)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:virus
|
| gptkbp:bfsLayer |
5
|
| gptkbp:bfsParent |
gptkb:Deltaretrovirinae
gptkb:HTLV-1 |
| gptkbp:affects |
immune system
|
| gptkbp:associated_with |
autoimmune diseases
cardiovascular diseases chronic inflammation opportunistic infections neurocognitive disorders |
| gptkbp:caused_by |
gptkb:T-cell_leukemia
|
| gptkbp:clinical_trial |
ongoing
|
| gptkbp:discovered_by |
gptkb:Robert_Gallo
|
| gptkbp:grooming_needs |
measured in blood
|
| gptkbp:healthcare |
gptkb:battle
|
| https://www.w3.org/2000/01/rdf-schema#label |
HTLV-3
|
| gptkbp:is_known_for |
gptkb:HIV-1
|
| gptkbp:is_popular_in |
approximately 38 million
|
| gptkbp:is_protected_by |
safe sex practices
screening blood donors |
| gptkbp:is_recognized_by |
gptkb:1980s
|
| gptkbp:is_vulnerable_to |
no effective vaccine
|
| gptkbp:lives_in |
gptkb:Caribbean
gptkb:Japan gptkb:South_America gptkb:sub-Saharan_Africa |
| gptkbp:related_to |
gptkb:AIDS
|
| gptkbp:research_areas |
health education
epidemiology public health interventions social determinants of health viral pathogenesis |
| gptkbp:research_focus |
vaccine development
treatment options |
| gptkbp:risk_factor |
multiple sexual partners
unprotected sex intravenous drug use mother with HTLV-3 |
| gptkbp:seed_dispersal |
RNA virus
|
| gptkbp:social_responsibility |
gptkb:Western_blot
gptkb:ELISA PCR blood test |
| gptkbp:symptoms |
fatigue
weight loss cough fever diarrhea neurological disorders night sweats swollen lymph nodes skin rashes |
| gptkbp:transmission |
sexual contact
blood transfusion mother to child |
| gptkbp:treatment |
gptkb:physicist
gptkb:drug supportive care chemotherapy clinical management antiviral agents immune modulation antiretroviral drugs |
| gptkbp:type_of |
Lentivirus
|